Objectives:

1. To review the evidence regarding the impact of calcium supplementation in adults with and without CKD.

2. To review the consequences of calcium exposure in the setting of CKD-MBD on cardiovascular disease and on survival.

3. To review the evidence supporting  avoidance of calcium exposure on patient centered clinical outcomes in CKD.

Session date: 
Wednesday, October 11, 2017 - 4:00pm to 5:00pm
Speaker Name: 
Dr. Donald Molony
Location: 
UCMC AMB S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.